Mesoblast (MESO) Invested Capital (2015 - 2026)

Mesoblast has reported Invested Capital for 9 years, with the latest figure at $126.9 million in Q4 2025.

• Quarterly Invested Capital rose 6.63% year-over-year to $126.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $482.1 million (up 5.29% YoY) and the FY2025 annual result came in at $121.9 million, up 6.6% from the prior year.
• Invested Capital grew to $126.9 million in Q4 2025 per MESO's latest filing, from $121.9 million in the prior quarter.
• Over five years, Invested Capital peaked at $126.9 million in Q4 2025 and troughed at $30.0 million in Q4 2022.
• A 5-year average of $93.9 million and a median of $101.5 million in 2022 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2023: Invested Capital tumbled 65.33% in 2022, then soared 285.87% in 2023.
• Over 5 years, Invested Capital stood at $86.5 million in 2021, then sank by 65.33% to $30.0 million in 2022, then jumped by 285.87% to $115.8 million in 2023, then grew by 2.78% to $119.0 million in 2024, then advanced by 6.63% to $126.9 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $126.9 million, $121.9 million, and $119.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.